Skip to search formSkip to main contentSkip to account menu

Neovastat

Known as: Neovastat/AE-941 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2004
Highly Cited
2004
A novel naturally occurring antiangiogenic agent isolated from cartilage, referred to as Neovastat (Æ-941), was examined for its… 
2004
2004
The plasminogen activator/plasmin system represents a key component of the proteolytic machinery underlying angiogenesis. In this… 
Highly Cited
2003
Highly Cited
2003
AE-941 (Neovastat), an antiangiogenic component extracted from cartilage, selectively competes for the binding of vascular… 
Highly Cited
2002
Highly Cited
2002
BACKGROUND renal cell carcinoma (RCC) is a potential target for anti-angiogenic drugs because of its high vascularization… 
Highly Cited
2002
Highly Cited
2002
Neovastat (AE-941), a naturally occurring multifunctional antiangiogenic agent, has been shown to inhibit key components of the… 
Highly Cited
2002
Highly Cited
2002
There is considerable evidence to support an immunopathogenic basis of psoriasis. However, changes such as altered angiogenesis… 
Highly Cited
2002
Highly Cited
2002
Bone metastases are generally associated with bone destruction which occurs in response to factors secreted by metastatic cells… 
Highly Cited
2002
Highly Cited
2002
PURPOSE Vascular endothelial growth factor (VEGF) is a potent regulator of angiogenesis, which exerts direct effects on vascular…